COMPARISON OF TREATMENT WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION VS. NATALIZUMAB, ALEMTUZUMAB, FINGOLIMOD AND MITOXANTRONE IN MULTIPLE SCLEROSIS

Grant number: 19-800 | Funding period: 2019 - 2021

Active

Researchers